StockData
Alaunos Therapeutics, Inc. logo

Alaunos Therapeutics, Inc. (TCRT) stock

TCRTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$1.72+0.06 (+3.61%)

Close on Nov 18, 2026Market cap $4.37MP/E –Yield –

Alaunos Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Alaunos Therapeutics's pe ratio was 0.1× on Jan 31, 2025, against 4.3× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Jan 31, 20250.1×−0.0
2024Dec 31, 20240.2×−5.5
2020Jan 31, 20205.7×−1.1
2019Dec 31, 20196.8×–

More Alaunos Therapeutics figures

See a number that looks wrong?